Takeda’s $4 Billion Psoriasis Pill Helped Clear Skin in Mid-Stage Study
Takeda Pharmaceutical Co.’s newly purchased oral psoriasis drug was safe and effective in a mid-stage study, highlighting its potential for treating the painful, incurable skin condition.









